Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 21 min ago
Peer-reviewedCC BY 4.0Frontiers in Endocrinology

Case Report: Intracranial germ cell tumors in girls presenting with peripheral precocious puberty and arginine vasopressin deficiency

  1. 1Department of Pediatrics, The First Affiliated Hospital, Sun Yat-Sen University

Abstract

Objective: This report summarizes the clinical characteristics of three female children with clinically diagnosed β-human chorionic gonadotropin (β-hCG)-secreting intracranial germ cell tumors (iGCTs) who presented with peripheral precocious puberty (PPP) and arginine vasopressin deficiency (AVP-D), with the aim of facilitating earlier diagnosis and treatment.

Methods: Clinical data of the 3 female patients with iGCTs with initial symptoms of PPP and AVP-D were retrospectively analyzed, and the relevant literature was reviewed.

Results: All the 3 female children first had polydipsia and polyuria, but their parents paid no attention or sought no medical help until the girls developed thelarche. The children were diagnosed with PPP and AVP-D. Moreover, their β-hCG levels were elevated in the peripheral blood (PB) and cerebrospinal fluid (CSF), and pituitary magnetic resonance imaging (MRI) revealed space-occupying lesions in the sellar region. Initial serum β-hCG concentrations in the 3 children were 5010.0, 314.3, and 202.8 mIU/mL, respectively. After regular chemotherapy and radiotherapy, β-hCG levels in the PB and CSF returned to normal, MRI scans revealed tumor reduction, Tanner stages regressed to stage I, and estradiol and testosterone levels decreased. Seven months after the treatment was completed, Patient 1 developed rapidly progressive central precocious puberty.

Conclusion: In children of either sex presenting with precocious puberty accompanied by multiple pituitary dysfunctions, including AVP-D, or mass effect manifestations, such as decreased visual acuity, routine serum β-hCG and AFP testing and contrast-enhanced sellar MRI are recommended to exclude organic lesions, including iGCTs.

Related

  1. Multidisciplinary Management of a Giant Ovarian Sertoli–Leydig Cell Tumor Presenting With Isosexual Precocious Puberty: A Pediatric Case Report
    Sanaa Bouramdane, Kenza Elmkaddem, Nawal Hammas +5
    Clinical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Diagnostic challenges of masked arginine vasopressin deficiency in neurosarcoidosis complicated by sodium–glucose cotransporter 2 inhibitor use
    JCEM case reportsPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMC
  3. Peripheral precocious puberty in a 4-month-old infant associated with an ESR1 variant: a case report
    Oxford medical case reportsPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  4. Ectopic rabphilin-3A expression in lung adenocarcinoma associated with paraneoplastic arginine vasopressin deficiency during anti-PD-L1 therapy: a case report.
    Haruki Fujisawa, Yosuke Eguchi, Naoko Iwata +8
    Journal for immunotherapy of cancerPeer-reviewedCC BY-NCFull textOncologyEurope PMC
  5. Acute colonic pseudo-obstruction with transient failure of oral desmopressin in adipsic arginine vasopressin deficiency.
    Wenyuan Li, Shahamah Ahmed, Sana Saeed +1
    JCEM case reportsPeer-reviewedCC BYFull textEndocrinology & metabolismEurope PMCPMC
BibTeX
@article{xin2026case,
  title = {{Case Report: Intracranial germ cell tumors in girls presenting with peripheral precocious puberty and arginine vasopressin deficiency}},
  author = {Wen Xin and Huamei Ma and Yanhong Li and Jun Zhang and Song Guo and Rujiang Zheng and Bing Wang and Huangmeng Xiao and Qiuli Chen},
  journal = {Frontiers in Endocrinology},
  year = {2026},
  month = oct,
  doi = {10.3389/fendo.2026.1886797},
  url = {https://www.frontiersin.org/articles/10.3389/fendo.2026.1886797/full},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Case Report: Intracranial germ cell tumors in girls presenting with peripheral precocious puberty and arginine vasopressin deficiency
AU  - Wen Xin
AU  - Huamei Ma
AU  - Yanhong Li
AU  - Jun Zhang
AU  - Song Guo
AU  - Rujiang Zheng
AU  - Bing Wang
AU  - Huangmeng Xiao
AU  - Qiuli Chen
PY  - 2026
DA  - 2026/10/16
JO  - Frontiers in Endocrinology
DO  - 10.3389/fendo.2026.1886797
UR  - https://www.frontiersin.org/articles/10.3389/fendo.2026.1886797/full
AB  - Objective: This report summarizes the clinical characteristics of three female children with clinically diagnosed β-human chorionic gonadotropin (β-hCG)-secreting intracranial germ cell tumors (iGCTs) who presented with peripheral precocious puberty (PPP) and arginine vasopressin deficiency (AVP-D), with the aim of facilitating earlier diagnosis and treatment.  Methods: Clinical data of the 3 female patients with iGCTs with initial symptoms of PPP and AVP-D were retrospectively analyzed, and the relevant literature was reviewed.  Results: All the 3 female children first had polydipsia and polyuria, but their parents paid no attention or sought no medical help until the girls developed thelarche. The children were diagnosed with PPP and AVP-D. Moreover, their β-hCG levels were elevated in the peripheral blood (PB) and cerebrospinal fluid (CSF), and pituitary magnetic resonance imaging (MRI) revealed space-occupying lesions in the sellar region. Initial serum β-hCG concentrations in the 3 children were 5010.0, 314.3, and 202.8 mIU/mL, respectively. After regular chemotherapy and radiotherapy, β-hCG levels in the PB and CSF returned to normal, MRI scans revealed tumor reduction, Tanner stages regressed to stage I, and estradiol and testosterone levels decreased. Seven months after the treatment was completed, Patient 1 developed rapidly progressive central precocious puberty.  Conclusion: In children of either sex presenting with precocious puberty accompanied by multiple pituitary dysfunctions, including AVP-D, or mass effect manifestations, such as decreased visual acuity, routine serum β-hCG and AFP testing and contrast-enhanced sellar MRI are recommended to exclude organic lesions, including iGCTs.
SN  - 1664-2392
ER  -